PKCδ promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway
ObjectiveColorectal cancer (CRC) is the third cause of expected cancer deaths both in men and women in the U.S. and the third most commonly diagnosed cancer in China Targeted therapy has been proven to improve overall survival for unresectable metastatic CRC. But the location of the primary tumor or...
Main Authors: | Hong-tao Jia, Yan-fei Shao, Xue-liang Zhou, Guang Yang, Ling Huang, Batuer Aikemu, Shu-chun Li, Cheng-sheng Ding, Xiao-dong Fan, Hi-ju Hong, Sen Zhang, Rui-jun Pan, Jing Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1026561/full |
Similar Items
-
ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer
by: Hong Hi-Ju, et al.
Published: (2022-09-01) -
An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients
by: Yanfei Shao, et al.
Published: (2021-06-01) -
Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signature
by: Xueliang Zhou, et al.
Published: (2022-08-01) -
Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
by: Chenxing Wang, et al.
Published: (2022-07-01) -
Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy
by: Enkui Zhang, et al.
Published: (2023-03-01)